InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,240.03
(
1.04%
)
US TECH 100
17,466.00
(
0.29%
)
Dow Jones
38,997.66
(
0.76%
)
Brent Oil
76.48
(
0.60%
)
Bitcoin
56,790.15
(
1.33%
)
Post# of 567
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Camaro1093

Send PM Follow Ignore
Followers 14
Posts 1226
Boards Moderated 1
Alias Born 08/16/2009

Camaro1093

Re: None

Wednesday, 01/06/2010 10:46:29 PM

Wednesday, January 06, 2010 10:46:29 PM

Post# of 567
Potential BioShocker: CXSPY.PK (ChemGenex Pharmaceuticals, Ltd.)

CXSPY is the American ADR for CXS.AX.

1 share of CXSPY.PK is worth 15 of CXS.AX.

In February, CXS.AX/CXSPY.PK has a meeting w/ the FDA Oncologic Drugs Advisory Committee for their drug "Omapro". It is intended for use in CML (Chronic Myeloid Leukemia) patients. If the ODAC vote is positive, CXS.AX/CXSPY.PK could really fly, in my opinion.

FYI: CXSFF.PK is NOT known by the company, I originally was going to buy those, but asked the company, and they said CXSFF.PK is not known to them. So the only one that the company recognizes is CXSPY.PK

Do your own DD before investing.

GLTA.

Visit my biotech investing board!: investorshub.advfn.com/boards/board.aspx?board_id=16653



GLTA.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up